Mesoblast Issues Warrants in $50 Million Agreement | Nasdaq

Mesoblast Issues Warrants In $50 Million Agreement | Nasdaq

2 weeks from now

Nov 7, 2024  · This agreement, which could provide the company with up to $50 million, follows FDA approval for their lead product Ryoncil®. The warrants, with an exercise price of $9.06 …

nasdaq.com

Mesoblast Option To Issue Up To US$50 Million Convertible

2 weeks from now

NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today …

biospace.com

#Mesoblast Secures $50 Million Funding With FDA Nod For Ryoncil ...

2 weeks from now

New York, Sept. 29, 2024 ?? Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines aimed at treating inflammatory diseases, has announced a …

csimarket.com

Mesoblast Secures $50M For RYONCIL Launch Prep - TipRanks

2 weeks from now

Oct 1, 2024  · The agreement includes the option for the investor to convert the notes into shares, with the arrangement aiding Mesoblast in strengthening its market strategy and securing …

tipranks.com

Mesoblast To Issue Up To $50 Million Of Convertible Notes For …

2 weeks from now

Sep 30, 2024  · -- Mesoblast said Sunday that it has entered an agreement with its largest shareholder, Gregory George, to issue up to $50 million convertible unsecured notes on …

marketscreener.com

Mesoblast Option To Issue Up To US$50 Million Convertible Notes …

2 weeks from now

Sep 30, 2024  · Mesoblast option to issue up to US$50 million convertible notes for product launch September 30, 2024 Australian Biotech Cell therapy company Mesoblast (ASX:MSB) has …

pharmadispatch.com

Mesoblast Option To Issue Up To US$50 Million Convertible Notes …

2 weeks from now

MESO Mesoblast Limited Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch. NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited …

advfn.com

Mesoblast Option To Issue Up To US$50 Million Convertible Notes …

2 weeks from now

NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammator

menafn.com

Mesoblast Issues 2 Million Warrants For Strategic Flexibility

2 weeks from now

Nov 13, 2024  · Mesoblast (MESO) has released an update.Mesoblast Limited has issued 2 million unquoted warrants as part of a US$50 million convertible note facility, which the company can …

nasdaq.com

Mesoblast Raises AU$260 Million Via Private Placement; Shares …

2 weeks from now

1 day ago  · -- Mesoblast completed a global private placement to existing US, UK, and Australian shareholders, raising AU$260 million at AU$2.50 per share, according to a Tuesday filing with …

marketscreener.com

D. Boral Capital Served As Placement Agent To Nature's Miracle …

2 weeks from now

1 day ago  · The Investor will also receive certain warrants to purchase shares of common stock upon the funding of each tranche. ... Nature's Miracle's common stock is greater than $1.50, …

einnews.com

Glucotrack Issues New Shares For Warrant Exchange

2 weeks from now

1 day ago  · Glucotrack, Inc. (NASDAQ:GCTK), a medical device company currently valued at $2.36 million and trading at $0.15 per share, has issued a significant number of new shares …

investing.com

VerifyMe Enters Into A Warrant Inducement Transaction For $4.7 …

2 weeks from now

VRME VerifyMe Inc VerifyMe Enters into a Warrant Inducement Transaction for $4.7 Million in Proceeds. VerifyMe Enters into a Warrant Inducement Transaction for $4.7 Million in Proceeds …

advfn.com

Nature's Miracle Holding, Inc. Announces Up To $29.7 Million

2 weeks from now

1 day ago  · The SPA allows Nature's Miracle, subject to customary conditions, to sell up to $29.7 million in the aggregate of a newly-designated class of convertible preferred stock to the Investor.

nasdaq.com